COFORGE

: Growth Amidst Financial Scrutiny 📈

Financial Recovery & Growth:

shares have largely recovered from a 9.4% drop following its Q1FY26 results. The stock's initial decline was fueled by concerns over heavy capital expenditure (capex) and lower-than-expected profitability, even as the company showcased strong sequential revenue growth of 8% in constant currency (CC). Strategic Investments & Capex: The company's significant capex, which surged 114% year-over-year in FY25 to ₹557 crore, is primarily attributed to strategic acquisitions like Cigniti and investments in a data center for a client. While this spending led to negative free cash flow (FCF) in FY25, analysts argue that this is not a structural issue. Excluding these one-time investments, Coforge's FCF conversion remains consistently healthy, reflecting strong cash management. Key Deals & Integration: In FY25, Coforge made a remarkable move by securing a 13-year, $1.56 billion deal with US-based travel tech firm, Sabre Technologies. The company also successfully integrated Cigniti Technologies' operations from Q2FY25. However, some analysts, like HSBC, caution that the Sabre deal carries execution risk due to Sabre's own financial challenges. Future Outlook & Concerns: Coforge aims to achieve a 14% EBIT margin for FY26, supported by lower expenses and sustained revenue growth. The company's 12-month executable order book has grown by 47% to $1.55 billion. Despite this, some market observers remain worried that consensus expectations for FY26-27 margins may not fully account for the execution risks associated with large deals and the Cigniti integration, suggesting potential downside.